Literature DB >> 22017877

mTOR generates an auto-amplification loop by triggering the βTrCP- and CK1α-dependent degradation of DEPTOR.

Shanshan Duan1, Jeffrey R Skaar, Shafi Kuchay, Alfredo Toschi, Naama Kanarek, Yinon Ben-Neriah, Michele Pagano.   

Abstract

DEPTOR is a recently identified inhibitor of the mTOR kinase that is highly regulated at the posttranslational level. In response to mitogens, we found that DEPTOR was rapidly phosphorylated on three serines in a conserved degron, facilitating binding and ubiquitylation by the F box protein βTrCP, with consequent proteasomal degradation of DEPTOR. Phosphorylation of the βTrCP degron in DEPTOR is executed by CK1α after a priming phosphorylation event mediated by either the mTORC1 or mTORC2 complexes. Blocking the βTrCP-dependent degradation of DEPTOR via βTrCP knockdown or expression of a stable DEPTOR mutant that is unable to bind βTrCP results in mTOR inhibition. Our findings reveal that mTOR cooperates with CK1α and βTrCP to generate an auto-amplification loop to promote its own full activation. Moreover, our results suggest that pharmacologic inhibition of CK1 may be a viable therapeutic option for the treatment of cancers characterized by activation of mTOR-signaling pathways.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017877      PMCID: PMC3212871          DOI: 10.1016/j.molcel.2011.09.005

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  28 in total

1.  DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

Authors:  Timothy R Peterson; Mathieu Laplante; Carson C Thoreen; Yasemin Sancak; Seong A Kang; W Michael Kuehl; Nathanael S Gray; David M Sabatini
Journal:  Cell       Date:  2009-05-14       Impact factor: 41.582

2.  mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.

Authors:  Daming Gao; Hiroyuki Inuzuka; Meng-Kwang Marcus Tan; Hidefumi Fukushima; Jason W Locasale; Pengda Liu; Lixin Wan; Bo Zhai; Y Rebecca Chin; Shavali Shaik; Costas A Lyssiotis; Steven P Gygi; Alex Toker; Lewis C Cantley; John M Asara; J Wade Harper; Wenyi Wei
Journal:  Mol Cell       Date:  2011-10-21       Impact factor: 17.970

Review 3.  mTOR signaling at a glance.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  J Cell Sci       Date:  2009-10-15       Impact factor: 5.285

Review 4.  mTOR signaling and drug development in cancer.

Authors:  Janet Dancey
Journal:  Nat Rev Clin Oncol       Date:  2010-03-16       Impact factor: 66.675

Review 5.  mTOR: from growth signal integration to cancer, diabetes and ageing.

Authors:  Roberto Zoncu; Alejo Efeyan; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-15       Impact factor: 94.444

6.  Identification of SCF ubiquitin ligase substrates by global protein stability profiling.

Authors:  Hsueh-Chi Sherry Yen; Stephen J Elledge
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

Review 7.  Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.

Authors:  Shomit Sengupta; Timothy R Peterson; David M Sabatini
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

8.  Control of chromosome stability by the beta-TrCP-REST-Mad2 axis.

Authors:  Daniele Guardavaccaro; David Frescas; N Valerio Dorrello; Angelo Peschiaroli; Asha S Multani; Timothy Cardozo; Anna Lasorella; Antonio Iavarone; Sandy Chang; Eva Hernando; Michele Pagano
Journal:  Nature       Date:  2008-03-20       Impact factor: 49.962

9.  betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis.

Authors:  Elinor Dehan; Florian Bassermann; Daniele Guardavaccaro; Gaia Vasiliver-Shamis; Michael Cohen; Kym N Lowes; Michael Dustin; David C S Huang; Jack Taunton; Michele Pagano
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

Review 10.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

View more
  114 in total

1.  Linking metabolism and cell cycle progression via the APC/CCdh1 and SCFβTrCP ubiquitin ligases.

Authors:  Shanshan Duan; Michele Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

2.  Cell signalling: mTOR targets its own inhibitor.

Authors:  Katharine H Wrighton
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-09       Impact factor: 94.444

Review 3.  mTOR signaling in stem and progenitor cells.

Authors:  Delong Meng; Anderson R Frank; Jenna L Jewell
Journal:  Development       Date:  2018-01-08       Impact factor: 6.868

4.  Rapid mitogenic regulation of the mTORC1 inhibitor, DEPTOR, by phosphatidic acid.

Authors:  Mee-Sup Yoon; Christina L Rosenberger; Cong Wu; Nga Truong; Jonathan V Sweedler; Jie Chen
Journal:  Mol Cell       Date:  2015-04-30       Impact factor: 17.970

5.  The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis.

Authors:  Kouhei Shimizu; Hidefumi Fukushima; Kohei Ogura; Evan C Lien; Naoe Taira Nihira; Jinfang Zhang; Brian J North; Ailan Guo; Katsuyuki Nagashima; Tadashi Nakagawa; Seira Hoshikawa; Asami Watahiki; Koji Okabe; Aya Yamada; Alex Toker; John M Asara; Satoshi Fukumoto; Keiichi I Nakayama; Keiko Nakayama; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Sci Signal       Date:  2017-01-03       Impact factor: 8.192

6.  mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.

Authors:  Daming Gao; Hiroyuki Inuzuka; Meng-Kwang Marcus Tan; Hidefumi Fukushima; Jason W Locasale; Pengda Liu; Lixin Wan; Bo Zhai; Y Rebecca Chin; Shavali Shaik; Costas A Lyssiotis; Steven P Gygi; Alex Toker; Lewis C Cantley; John M Asara; J Wade Harper; Wenyi Wei
Journal:  Mol Cell       Date:  2011-10-21       Impact factor: 17.970

7.  The endosomal sorting complex required for transport pathway mediates chemokine receptor CXCR4-promoted lysosomal degradation of the mammalian target of rapamycin antagonist DEPTOR.

Authors:  Rita Verma; Adriano Marchese
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

8.  XPLN is an endogenous inhibitor of mTORC2.

Authors:  Nidhi Khanna; Yimin Fang; Mee-Sup Yoon; Jie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 9.  Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.

Authors:  Chuan-Ming Xie; Wenyi Wei; Yi Sun
Journal:  J Genet Genomics       Date:  2013-02-10       Impact factor: 4.275

Review 10.  Cullin-RING Ligases as attractive anti-cancer targets.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.